Found 3 hits Enz. Inhib. hit(s) with Target = 'IgG receptor FcRn large subunit p51' and Ligand = 'BDBM50314106' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
IgG receptor FcRn large subunit p51
(Homo sapiens (Human)) | BDBM50314106
((S)-N1-((S)-1-((S)-1-((3R,8R,11S,17S,20S,29S,32S,3...)Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O |r| Show InChI InChI=1S/C85H117N25O23S2/c1-44(2)30-55-77(126)102-54(31-49-21-23-51(113)24-22-49)71(120)84(133)110-29-13-20-63(110)82(131)107-60(80(129)105-59(35-65(87)115)74(123)96-40-69(119)109-28-12-19-62(109)72(88)121)41-134-135-42-61(106-78(127)57(33-48-16-9-6-10-17-48)104-75(124)52(18-11-27-92-85(89)90)101-76(125)53(98-46(4)112)25-26-64(86)114)81(130)108-70(45(3)111)83(132)95-39-68(118)100-58(34-50-36-91-43-97-50)79(128)103-56(32-47-14-7-5-8-15-47)73(122)94-37-66(116)93-38-67(117)99-55/h5-10,14-17,21-24,36,43-45,52-63,70,111,113H,11-13,18-20,25-35,37-42H2,1-4H3,(H2,86,114)(H2,87,115)(H2,88,121)(H,91,97)(H,93,116)(H,94,122)(H,95,132)(H,96,123)(H,98,112)(H,99,117)(H,100,118)(H,101,125)(H,102,126)(H,103,128)(H,104,124)(H,105,129)(H,106,127)(H,107,131)(H,108,130)(H4,89,90,92)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,70+/m1/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Syntonix Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISA |
J Med Chem 53: 1587-96 (2010)
Article DOI: 10.1021/jm901128z BindingDB Entry DOI: 10.7270/Q23R0T1H |
More data for this Ligand-Target Pair | |
IgG receptor FcRn large subunit p51
(Homo sapiens (Human)) | BDBM50314106
((S)-N1-((S)-1-((S)-1-((3R,8R,11S,17S,20S,29S,32S,3...)Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O |r| Show InChI InChI=1S/C85H117N25O23S2/c1-44(2)30-55-77(126)102-54(31-49-21-23-51(113)24-22-49)71(120)84(133)110-29-13-20-63(110)82(131)107-60(80(129)105-59(35-65(87)115)74(123)96-40-69(119)109-28-12-19-62(109)72(88)121)41-134-135-42-61(106-78(127)57(33-48-16-9-6-10-17-48)104-75(124)52(18-11-27-92-85(89)90)101-76(125)53(98-46(4)112)25-26-64(86)114)81(130)108-70(45(3)111)83(132)95-39-68(118)100-58(34-50-36-91-43-97-50)79(128)103-56(32-47-14-7-5-8-15-47)73(122)94-37-66(116)93-38-67(117)99-55/h5-10,14-17,21-24,36,43-45,52-63,70,111,113H,11-13,18-20,25-35,37-42H2,1-4H3,(H2,86,114)(H2,87,115)(H2,88,121)(H,91,97)(H,93,116)(H,94,122)(H,95,132)(H,96,123)(H,98,112)(H,99,117)(H,100,118)(H,101,125)(H,102,126)(H,103,128)(H,104,124)(H,105,129)(H,106,127)(H,107,131)(H,108,130)(H4,89,90,92)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,70+/m1/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | 3.70E+4 | n/a | n/a | n/a | 7.4 | n/a |
Syntonix Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Binding affinity to soluble human FcRn at pH 7.4 by surface plasmon resonance assay |
J Med Chem 53: 1587-96 (2010)
Article DOI: 10.1021/jm901128z BindingDB Entry DOI: 10.7270/Q23R0T1H |
More data for this Ligand-Target Pair | |
IgG receptor FcRn large subunit p51
(Homo sapiens (Human)) | BDBM50314106
((S)-N1-((S)-1-((S)-1-((3R,8R,11S,17S,20S,29S,32S,3...)Show SMILES CC(C)C[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O |r| Show InChI InChI=1S/C85H117N25O23S2/c1-44(2)30-55-77(126)102-54(31-49-21-23-51(113)24-22-49)71(120)84(133)110-29-13-20-63(110)82(131)107-60(80(129)105-59(35-65(87)115)74(123)96-40-69(119)109-28-12-19-62(109)72(88)121)41-134-135-42-61(106-78(127)57(33-48-16-9-6-10-17-48)104-75(124)52(18-11-27-92-85(89)90)101-76(125)53(98-46(4)112)25-26-64(86)114)81(130)108-70(45(3)111)83(132)95-39-68(118)100-58(34-50-36-91-43-97-50)79(128)103-56(32-47-14-7-5-8-15-47)73(122)94-37-66(116)93-38-67(117)99-55/h5-10,14-17,21-24,36,43-45,52-63,70,111,113H,11-13,18-20,25-35,37-42H2,1-4H3,(H2,86,114)(H2,87,115)(H2,88,121)(H,91,97)(H,93,116)(H,94,122)(H,95,132)(H,96,123)(H,98,112)(H,99,117)(H,100,118)(H,101,125)(H,102,126)(H,103,128)(H,104,124)(H,105,129)(H,106,127)(H,107,131)(H,108,130)(H4,89,90,92)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,70+/m1/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | 5.30E+3 | n/a | n/a | n/a | 6.0 | n/a |
Syntonix Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Binding affinity to soluble human FcRn at pH 6 by surface plasmon resonance assay |
J Med Chem 53: 1587-96 (2010)
Article DOI: 10.1021/jm901128z BindingDB Entry DOI: 10.7270/Q23R0T1H |
More data for this Ligand-Target Pair | |